[HTML][HTML] Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
Background Cystic fibrosis lung disease is characterized by chronic bacterial infections in
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
MS Muhlebach, W Sha, B MacIntosh, TJ Kelley… - 2019 - agris.fao.org
Background: Cystic fibrosis lung disease is characterized by chronic bacterial infections in
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
[PDF][PDF] Metabolism Open
MS Muhlebach, W Sha, B MacIntosh, TJ Kelley… - 2019 - scienceopen.com
abstract Background: Cystic fibrosis lung disease is characterized by chronic bacterial
infections in the setting of mucus abnormalities. Patients experience periodic exacerbations …
infections in the setting of mucus abnormalities. Patients experience periodic exacerbations …
Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
MS Muhlebach, W Sha, B MacIntosh… - Metabolism …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Cystic fibrosis lung disease is characterized by chronic bacterial infections in
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
[HTML][HTML] Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation
MS Muhlebach, W Sha, B MacIntosh, TJ Kelley… - Metabolism …, 2019 - ncbi.nlm.nih.gov
Background Cystic fibrosis lung disease is characterized by chronic bacterial infections in
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation.
MS Muhlebach, W Sha, B MacIntosh, TJ Kelley… - Metabolism …, 2019 - europepmc.org
Background Cystic fibrosis lung disease is characterized by chronic bacterial infections in
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …
the setting of mucus abnormalities. Patients experience periodic exacerbations that manifest …